Metastatic Urothelial Cancer Completed Phase 2 / 3 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0066157 (Metastatic Urothelial Cancer)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02240017A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.Treatment